Researchers evaluated the efficacy of guselkumab for the treatment of active psoriatic arthritis.
All articles by Inga Back, MPH
Researchers evaluated the clinical characteristics, disease burden, and treatment of patients with peripheral spondyloarthritis with and without psoriasis.
Using a set of parallel case-control studies, the shared and different risk factors for psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis were identified.
Researchers developed a working core outcome set with the objective of improving clinical studies in cutaneous lupus erythematosus.
Using the ACR/EULAR criteria, researchers studied the population-based incidence, prevalence, and mortality of dermatomyositis in adults.
Researchers studied the prevalence and 4-year incidence of acute anterior uveitis, inflammatory bowel disease, and psoriasis, and explore the associations between extraskeletal manifestations and clinical disease outcomes in axial spondyloarthritis.
Researchers examined the association between psoriasis severity and the development of psoriatic arthritis.
Researchers identified the transcriptional profile and composition of immune cells in the peripheral blood of patients with rheumatoid arthritis, systemic lupus erythematosus, and primary Sjögren syndrome.
The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.
Researchers studied the effect of apremilast on body weight and composition, glucose homeostasis, lipid profiles, and vascular function in psoriatic disease.